Telegraph Hill Partners

Mosaic Biosciences, Inc. develops biomaterials for tissue engineering applications. Its technology platform provides biomaterial for various medical applications, such as drug delivery, regenerative medicine, stem cell therapies, and sealants and adhesion barriers. Mosaic Biosciences, Inc. has a strategic collaboration with Catalyst Biosciences. The company was incorporated in 2009 and is based in Boulder, Colorado.

Accumetrics is a privately-held company that develops, manufactures, and markets the VerifyNow System, a comprehensive suite of assays for the assessment of platelet function. Accumetrics, based in San Diego, California, was founded in 1996, sold to Radiometer in 2000, and repurchased by company management and investors in 2003.

Nivagen Pharmaceuticals, Inc. engages in the development, acquisition, and sales of generic prescription drugs and over the counter products for the North American market. The company sells its products through chain drug stores, regional wholesalers, mass merchandisers, hospitals, GPOs, mail order pharmacies, and other buying groups. Nivagen Pharmaceuticals, Inc. was incorporated in 2009 and is based in Sacramento, California.

Developer and manufacturer of cell and gene therapies intended to facilitate the advancement of advanced therapies. The company offers development and clinical manufacturing for CAR-T, tumor-infiltrating lymphocyte therapy and immunotherapy, enabling clients to realize the potential of these powerful therapeutics and helps in saving patients' lives. They focus on providing cGMP cellular products and services to scientists and physicians working with cell and gene therapies, as well as process development and manufacturing expertise. The mission is to accelerate the development of cellular therapies and to enable these powerful medications to reach their full potential, saving lives now and improving lives tomorrow. establishing a new benchmark in the industry.

Carterra provides biotechnology solutions that develop and commercialize novel micro-array deposition technologies. The company provides users with instruments and services, which enable multiplexing on planar array surfaces. It also offers Continuous Flow Microspotter (CFM), which includes an array printing instrument and a microfluidic print head. Its products include spot CFM printhead, which uses a network of microchannels to deposit samples at one time in a block; and CFM instrument, which uses built-in sensors and pumps to control the flow within the CFM print head. It was founded in 2005 and headquartered in Salt Lake City, Utah.

ESTECH is a privately held medical device manufacturing and distribution company located in San Ramon, California. The company was founded by Arthur and Raymond Bertolero in 1996 with an emphasis on least invasive products for cardiac surgery. ESTECH has worldwide distribution and has consistently attracted goal oriented professionals who represent the brightest minds in the medical device industry. The in-depth professional experience and tireless dedication of the ESTECH Team has allowed the company to achieve rapid and sustained success in this highly competitive environment. ESTECH is proud of each employee from every department and thanks them for their contribution and support.

AngioScore Inc. develops, manufactures and markets the AngioSculpt Scoring Balloon Catheter for both the coronary and peripheral interventional markets. Designed specifically to address the limitations of conventional angioplasty balloon catheters, AngioSculpt combines a semi-compliant balloon with an innovative nitinol scoring element.

ESTECH is a privately held medical device manufacturing and distribution company located in San Ramon, California. The company was founded by Arthur and Raymond Bertolero in 1996 with an emphasis on least invasive products for cardiac surgery. ESTECH has worldwide distribution and has consistently attracted goal oriented professionals who represent the brightest minds in the medical device industry. The in-depth professional experience and tireless dedication of the ESTECH Team has allowed the company to achieve rapid and sustained success in this highly competitive environment. ESTECH is proud of each employee from every department and thanks them for their contribution and support.

Dynex Technologies, Inc. designs, engineers, manufactures, and distributes ELISA microplate workstations, laboratory instruments, and associated consumables and accessories. The company also offers technical support services. It provides its products through distributors in the United States, Canada, Mexico and South America, Asia, Europe, the Middle East and Africa, and internationally, as well as online. Dynex Technologies, Inc. was formerly known as Dynatech Laboratories, Inc. and changed its name to Dynex Technologies, Inc. in 1996. The company was founded in 1952 and is based in Chantilly, Virginia. Dynex Technologies, Inc. is a former subsidiary of Magellan Diagnostics, Inc.

Asuragen is a fully integrated diagnostics company focused on molecular oncology and early detection of cancer, with an emphasis on microRNA. Asuragen's current diagnostics product portfolio consists of Signature® Genetic and Oncology Testing products, as well as industry leading controls and standards engineered using its patented Armored RNA® technology. In addition to its diagnostics products, Asuragen offers GLP testing services and an established cGMP manufacturing facility that allow it to span the spectrum of discovery, testing, production and commercialization.

Carterra provides biotechnology solutions that develop and commercialize novel micro-array deposition technologies. The company provides users with instruments and services, which enable multiplexing on planar array surfaces. It also offers Continuous Flow Microspotter (CFM), which includes an array printing instrument and a microfluidic print head. Its products include spot CFM printhead, which uses a network of microchannels to deposit samples at one time in a block; and CFM instrument, which uses built-in sensors and pumps to control the flow within the CFM print head. It was founded in 2005 and headquartered in Salt Lake City, Utah.

Althea Technologies, located in San Diego, CA, is a contract development and manufacturing organization that specializes in cGMP manufacturing, analytical development, aseptic filling into vials & syringes, and protein delivery technology for recombinant protein and parenteral products. In a single location, Althea has the capacity to meet your early-stage and commercial requirements.

Carterra provides biotechnology solutions that develop and commercialize novel micro-array deposition technologies. The company provides users with instruments and services, which enable multiplexing on planar array surfaces. It also offers Continuous Flow Microspotter (CFM), which includes an array printing instrument and a microfluidic print head. Its products include spot CFM printhead, which uses a network of microchannels to deposit samples at one time in a block; and CFM instrument, which uses built-in sensors and pumps to control the flow within the CFM print head. It was founded in 2005 and headquartered in Salt Lake City, Utah.

AngioScore Inc. develops, manufactures and markets the AngioSculpt Scoring Balloon Catheter for both the coronary and peripheral interventional markets. Designed specifically to address the limitations of conventional angioplasty balloon catheters, AngioSculpt combines a semi-compliant balloon with an innovative nitinol scoring element.

Precision Nanosystems, Inc. develops tools and processes for the development and manufacture of nanoparticles for use as medicines and in medical research. It offers NanoAssemblr benchtop instrument for prototyping of nanoparticles, as well as for the development of nanoparticle based drugs delivering RNA, small-molecule, and protein therapeutics. The company also provides Neuro9Kit for the study of gene function in neurons and glia cells, as well as potent delivery to primary cells; Test9Kit for the study of gene function in various cell types; Hepato9Kit for the study of gene function in the liver; and Ignite for clinical manufacturing. In addition, it provides instruments, reagents, and services to life sciences researchers through its distributors in Canada and internationally. Precision Nanosystems, Inc. has a strategic partnership with Sirnaomics Inc. Precision Nanosystems, Inc. was incorporated in 2010 and is based in Vancouver, Canada.

Emerging Therapy Solutions, Inc. engages in the outsourced management of cell and gene therapy treatments for health care payers. It offers services ranging from patient management to data collection, analysis, reporting, and claims administration. The company was incorporated in 2018 and is based in Bloomington, Minnesota.

Precision Nanosystems develops tools and processes for the development and manufacture of nanoparticles for use as medicines and in medical research. It offers NanoAssemblr benchtop instrument for prototyping of nanoparticles, as well as for the development of nanoparticle-based drugs delivering RNA, small-molecule, and protein therapeutics. The company also provides Neuro9Kit for the study of gene function in neurons and glial cells, as well as potent delivery to primary cells; Test9Kit for the study of gene function in various cell types; and Hepato9Kit for the study of gene function in the liver. In addition, it provides instruments, reagents, and services to the life sciences researchers.

PneumRx, Inc., a start-up medical device company, develops minimally invasive treatments for emphysema patients. The company develops RePneu Lung Volume Reduction Coil, an investigational device for treating emphysema patients. PneumRx, Inc. was founded in 2004 and is based in Mountain View, California.

Asuragen is a fully integrated diagnostics company focused on molecular oncology and early detection of cancer, with an emphasis on microRNA. Asuragen's current diagnostics product portfolio consists of Signature® Genetic and Oncology Testing products, as well as industry leading controls and standards engineered using its patented Armored RNA® technology. In addition to its diagnostics products, Asuragen offers GLP testing services and an established cGMP manufacturing facility that allow it to span the spectrum of discovery, testing, production and commercialization.

Freedom Innovations LLC is a company that offers lower limb solutions for low to high mobility users.

Nivagen Pharmaceuticals, Inc. engages in the development, acquisition, and sales of generic prescription drugs and over the counter products for the North American market. The company sells its products through chain drug stores, regional wholesalers, mass merchandisers, hospitals, GPOs, mail order pharmacies, and other buying groups. Nivagen Pharmaceuticals, Inc. was incorporated in 2009 and is based in Sacramento, California.

Precision Nanosystems develops tools and processes for the development and manufacture of nanoparticles for use as medicines and in medical research. It offers NanoAssemblr benchtop instrument for prototyping of nanoparticles, as well as for the development of nanoparticle-based drugs delivering RNA, small-molecule, and protein therapeutics. The company also provides Neuro9Kit for the study of gene function in neurons and glial cells, as well as potent delivery to primary cells; Test9Kit for the study of gene function in various cell types; and Hepato9Kit for the study of gene function in the liver. In addition, it provides instruments, reagents, and services to the life sciences researchers.

Emerging Therapy Solutions, Inc. engages in the outsourced management of cell and gene therapy treatments for health care payers. It offers services ranging from patient management to data collection, analysis, reporting, and claims administration. The company was incorporated in 2018 and is based in Bloomington, Minnesota.

Cell Microsystems is an early growth stage company that develops, manufactures, and markets innovative products for single cell biology. The Company’s proprietary CellRaft™ Technology enables high-efficiency sorting and isolation of single cells under standard culture conditions resulting in unperturbed phenotypes and high viability. Coupled with the Company’s automated imaging platform, a user can select a cell in real-time and ‘track and trace’ that cell through imaging, collection and downstream analysis. By sorting during real-time imaging, no cells are wasted enabling single cell isolation from even small, precious samples. The CellRaft Technology offers scalable solutions making cell separation technology available for every lab.

TrakCel's proven technology integrates and orchestrates every aspect of Autologous and Allogeneic supply chains in a scalable, compliant and validated technology platform.

Nimble Therapeutics, Inc. operates as a biotechnology company. The company was incorporated in 2019 and is based in Madison, Wisconsin.

LDR Holding Corporation develops and markets implantable spine systems and instrumentation for patients and the surgeon community in the United States and internationally. Its spinal surgery solutions include cervical and lumbar artificial disc systems, pedicle screw systems, implant systems, cervical cages, synthetic bone substitutes, and ALIF and TLIF devices, as well as VerteBRIDGE product, a direct lateral and oblique lumbar system for surgical applications. The company offers its products through partnerships with surgeons and distributors in Australia, Argentina, Austria, Belgium, Denmark, Greece, the Netherlands, Italy, Japan, Korea, Mexico, Malaysia, Peru, Portugal, South Africa, Spain, China, Switzerland, Taiwan, Thailand, Turkey, and the United Kingdom. LDR Holding Corporation was formerly known as LDR Spine USA, Inc. and changed its name after acquiring LDR Médical. The company was founded in 2004 and is based in Austin, Texas with additional offices in Troyes, France; Beijing, China; Sao Paolo, Brazil; and Munich, Germany.

Cell Microsystems is an early growth stage company that develops, manufactures, and markets innovative products for single cell biology. The Company’s proprietary CellRaft™ Technology enables high-efficiency sorting and isolation of single cells under standard culture conditions resulting in unperturbed phenotypes and high viability. Coupled with the Company’s automated imaging platform, a user can select a cell in real-time and ‘track and trace’ that cell through imaging, collection and downstream analysis. By sorting during real-time imaging, no cells are wasted enabling single cell isolation from even small, precious samples. The CellRaft Technology offers scalable solutions making cell separation technology available for every lab.

Confirma is the only company that develops and markets an MRI-CAD system, CADstream, revolutionizing MRI study analysis and reporting through automated and standardized processing. CADstream automates the analysis and interventional guidance of MRI studies, providing higher quality imaging studies, lower costs for radiology practices and improved communication tools for physicians and patients. CADstream can be integrated into any workflow scenario and is compatible with all MRI scanners and PACS.

Akoya Biosciences is a spatial biology company offering the most comprehensive, end-to-end solutions for high-parameter tissue analysis from discovery through clinical and translational research, enabling the development of more precise therapies for immuno-oncology and other drug development applications. The company has two industry-leading platforms that empower investigators and researchers to gain a deeper understanding of complex diseases such as cancer, and autoimmune or neurological disorders. The CODEX system is the only benchtop platform that can efficiently quantify more than 40 biomarkers and is ideally suited for biomarker discovery. The Phenoptics platform is the only end-to-end multiplexed immunofluorescence solution with the robustness and high throughput necessary for translational research and clinical trials.

Nimble Therapeutics is a developer of a drug discovery platform intended to bring the power of massively parallel chemical synthesis to drug discovery. The company uses its unique maskless chemical synthesis platform to synthesize and systematically discover novel medicines in a variety of therapeutic areas, providing customers aid in the empirical optimization of molecules with more favorable drug-like properties.

MEDPRICER.COM, INC. develops purchased services cost management solution for the healthcare industry. The company owns and operates mSource, a purchased services cost management software platform that empowers healthcare providers to discover, organize, benchmark, and manage their service provider spending. It also offers precision benchmark reports, project management, and advisory services. The company was founded in 2004 and is based in Guilford, Connecticut with an additional office in Walnut Creek, California. As of October 28, 2019, MEDPRICER.COM, INC. operates as a subsidiary of Premier, Inc.

Aquaro Histology, Inc. engages in manufacturing of a section mounting system to streamline the histology workflow. The company's product automates the placement of paraffin-embedded tissue sections onto slides. It's product is used in laboratories to enhance patient diagnosis and care. The company was founded in 2017 and is headquartered in Ann Arbor, Michigan.

ESTECH is a privately held medical device manufacturing and distribution company located in San Ramon, California. The company was founded by Arthur and Raymond Bertolero in 1996 with an emphasis on least invasive products for cardiac surgery. ESTECH has worldwide distribution and has consistently attracted goal oriented professionals who represent the brightest minds in the medical device industry. The in-depth professional experience and tireless dedication of the ESTECH Team has allowed the company to achieve rapid and sustained success in this highly competitive environment. ESTECH is proud of each employee from every department and thanks them for their contribution and support.

Akoya Biosciences is a spatial biology company offering the most comprehensive, end-to-end solutions for high-parameter tissue analysis from discovery through clinical and translational research, enabling the development of more precise therapies for immuno-oncology and other drug development applications. The company has two industry-leading platforms that empower investigators and researchers to gain a deeper understanding of complex diseases such as cancer, and autoimmune or neurological disorders. The CODEX system is the only benchtop platform that can efficiently quantify more than 40 biomarkers and is ideally suited for biomarker discovery. The Phenoptics platform is the only end-to-end multiplexed immunofluorescence solution with the robustness and high throughput necessary for translational research and clinical trials.

Technomed Engineering B.V., trading as Technomed Europe, engages in the development, production, and marketing of neurodiagnostic accessories for the neurophysiology market in Europe and internationally. The company’s products include reusable concentric, single fiber, monopolar needle, bar, bipolar felt pad, small stimulating, digital ring, surface, detachable stimulating and recording, grounding plate and wrap around, disposable and reusable subdermal needle, twisted disposable subdermal needle, disposable subdermal hooked needle, disposable and reusable cup, ear clip, and nasopharyngeal electrodes. Its products also comprise disposable adhesive surface, as well as concentric, monopolar, and hypodermic needle electrodes; reusable cables, sharpening kits for reusable needle electrodes, replacement felt pads, straps, alligator and grounding alligator clips, and electrode positioning systems; and collodions, preps, and pastes. The company’s disposable and reusable needle and surface electrodes are used to perform clinical/neurophysiologic examinations, such as muscle and brain activity registration, inoperative monitoring, nerve conduction studies, and evoked potentials. In addition, Technomed Engineering offers temperature probes, and medical diagnostic accessories of other manufacturers, such as ECG cables and lead wires. It sells its products through a distributor network in Belgium, Bulgaria, Croatia, the Czech Republic, Estonia, Finland, France, Germany, Greece, Italy, the Republic of Korea, Lithuania, Norway, Portugal, Sweden, Serbia, Spain, the Netherlands, Turkey, and the United Kingdom, as well as original equipment manufacturers. The company was founded in 1994 and is based in Beek, the Netherlands.

Dynex Technologies, Inc. designs, engineers, manufactures, and distributes ELISA microplate workstations, laboratory instruments, and associated consumables and accessories. The company also offers technical support services. It provides its products through distributors in the United States, Canada, Mexico and South America, Asia, Europe, the Middle East and Africa, and internationally, as well as online. Dynex Technologies, Inc. was formerly known as Dynatech Laboratories, Inc. and changed its name to Dynex Technologies, Inc. in 1996. The company was founded in 1952 and is based in Chantilly, Virginia. Dynex Technologies, Inc. is a former subsidiary of Magellan Diagnostics, Inc.

BioVentrix is a medical device company engaged in the improvement of treatments available for congestive heart failure. It is a biotechnology company that improves and expands the treatments available for congestive heart failure (CHF) caused by ischemic cardiomyopathy, through the development of less invasive and catheter-based approaches. The company was founded in 2003 and is headquartered in San Ramon, California, United States.

ESTECH is a privately held medical device manufacturing and distribution company located in San Ramon, California. The company was founded by Arthur and Raymond Bertolero in 1996 with an emphasis on least invasive products for cardiac surgery. ESTECH has worldwide distribution and has consistently attracted goal oriented professionals who represent the brightest minds in the medical device industry. The in-depth professional experience and tireless dedication of the ESTECH Team has allowed the company to achieve rapid and sustained success in this highly competitive environment. ESTECH is proud of each employee from every department and thanks them for their contribution and support.

PneumRx, Inc., a start-up medical device company, develops minimally invasive treatments for emphysema patients. The company develops RePneu Lung Volume Reduction Coil, an investigational device for treating emphysema patients. PneumRx, Inc. was founded in 2004 and is based in Mountain View, California.

RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood. RareCyte is dedicated to bringing its innovative technology to the Life Sciences research, drug development, and diagnostic markets providing new tools to answer difficult questions related to cancer and cardiovascular disease. RareCyte's ground-breaking AccuCyte system is an open platform for the unbiased discovery and isolation of circulating tumor cells (CTCs) and circulating endothelial cells (CECs) from whole blood.

RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood. RareCyte is dedicated to bringing its innovative technology to the Life Sciences research, drug development, and diagnostic markets providing new tools to answer difficult questions related to cancer and cardiovascular disease. RareCyte's ground-breaking AccuCyte system is an open platform for the unbiased discovery and isolation of circulating tumor cells (CTCs) and circulating endothelial cells (CECs) from whole blood.

Argonaut provides contract manufacturing for biopharmaceutical, diagnostics and life science organizations. The company's services include high-yield aseptic fill/finish, reagent formulation, filling, kitting, lyophilization, and analytical support. It provides a wide range of diagnostics and drug products for diverse outsourcing needs.

Argonaut provides contract manufacturing for biopharmaceutical, diagnostics and life science organizations. The company's services include high-yield aseptic fill/finish, reagent formulation, filling, kitting, lyophilization, and analytical support. It provides a wide range of diagnostics and drug products for diverse outsourcing needs.

Specific Diagnostics, LLC develops solutions for the detection, identification, and antibiotic susceptibility testing. It offers Specific Reveal system that provides antibiotic susceptibility results that allows clinics to deploy specific solutions. Specific Diagnostics, LLC was founded in 2011 and is headquartered in West Palm Beach, Florida.